Strategies for improving the efficacy of anti-L1CAM radioimmunotherapy in an ovarian cancer model

Download
Abstract (Adobe PDF, 131.1Kb)
Fulltext (Adobe PDF, 20.50Mb)
Thumbnail
Embargoed until 2019-03-02
Author
Lindenblatt, Dennis
Date
2015
Type
  • Doctoral Thesis
Permanent link
https://doi.org/10.3929/ethz-a-010603304
Publication status
published
External links
Search via SFX
Contributors
Examiner: Schibli, Roger
Examiner: Ametamey, Simon Mensah
Publisher
ETH-Zürich
Subject
OVARIALKARZINOME (GYNÄKOLOGIE); RADIOIMMUNTHERAPIE; MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); THERAPEUTISCHE PHARMAKOLOGIE, VERABREICHUNG VON ARZNEIMITTELN, CHEMOTHERAPIE, KLINISCHE PHARMAKOLOGIE; THERAPIEERFOLGSEVALUATION (MEDIZIN); OVARIAN CANCER (GYNAECOLOGY); RADIOIMMUNOTHERAPY; MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); CLINICAL PHARMACOLOGY, THERAPEUTICAL PHARMACOLOGY, CHEMOTHERAPY, MEDICATION, ADMINISTRATION OF DRUGS; THERAPY SUCCESS EVALUATION (MEDICINE)
Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.
03688 - Schibli, Roger / Schibli, Roger  
More
Show all metadata
ETH Bibliography
yes
Altmetrics